314 related articles for article (PubMed ID: 37146581)
1. Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation.
Vandana JJ; Manrique C; Lacko LA; Chen S
Cell Stem Cell; 2023 May; 30(5):571-591. PubMed ID: 37146581
[TBL] [Abstract][Full Text] [Related]
2. Human Pluripotent Stem Cell-Derived Hepatocyte-Like Cells and Organoids for Liver Disease and Therapy.
Li Y; Yang X; Plummer R; Hayashi Y; Deng XS; Nie YZ; Taniguchi H
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638810
[TBL] [Abstract][Full Text] [Related]
3. Modeling cancer progression using human pluripotent stem cell-derived cells and organoids.
Zhang M; Vandana JJ; Lacko L; Chen S
Stem Cell Res; 2020 Dec; 49():102063. PubMed ID: 33137568
[TBL] [Abstract][Full Text] [Related]
4. The Use of Stem Cell-Derived Organoids in Disease Modeling: An Update.
Azar J; Bahmad HF; Daher D; Moubarak MM; Hadadeh O; Monzer A; Al Bitar S; Jamal M; Al-Sayegh M; Abou-Kheir W
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299287
[TBL] [Abstract][Full Text] [Related]
5. Constructing and Deconstructing Cancers using Human Pluripotent Stem Cells and Organoids.
Smith RC; Tabar V
Cell Stem Cell; 2019 Jan; 24(1):12-24. PubMed ID: 30581078
[TBL] [Abstract][Full Text] [Related]
6. Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids.
Mun SJ; Ryu JS; Lee MO; Son YS; Oh SJ; Cho HS; Son MY; Kim DS; Kim SJ; Yoo HJ; Lee HJ; Kim J; Jung CR; Chung KS; Son MJ
J Hepatol; 2019 Nov; 71(5):970-985. PubMed ID: 31299272
[TBL] [Abstract][Full Text] [Related]
7. Rethinking organoid technology through bioengineering.
Garreta E; Kamm RD; Chuva de Sousa Lopes SM; Lancaster MA; Weiss R; Trepat X; Hyun I; Montserrat N
Nat Mater; 2021 Feb; 20(2):145-155. PubMed ID: 33199860
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional cardiac models: a pre-clinical testing platform.
Groen E; Mummery CL; Yiangou L; Davis RP
Biochem Soc Trans; 2024 Jun; 52(3):1045-1059. PubMed ID: 38778769
[TBL] [Abstract][Full Text] [Related]
9. Advancing Drug Discovery for Neurological Disorders Using iPSC-Derived Neural Organoids.
Costamagna G; Comi GP; Corti S
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800815
[TBL] [Abstract][Full Text] [Related]
10. Human pluripotent stem cell-based cardiovascular disease modeling and drug discovery.
Liu G; Liu Z; Cao N
Pflugers Arch; 2021 Jul; 473(7):1087-1097. PubMed ID: 33686477
[TBL] [Abstract][Full Text] [Related]
11. The application of brain organoid for drug discovery in mitochondrial diseases.
Liang KX
Int J Biochem Cell Biol; 2024 May; 170():106556. PubMed ID: 38423381
[TBL] [Abstract][Full Text] [Related]
12. Human pluripotent stem cell-derived lung organoids: Potential applications in development and disease modeling.
Tian L; Gao J; Garcia IM; Chen HJ; Castaldi A; Chen YW
Wiley Interdiscip Rev Dev Biol; 2021 Nov; 10(6):e399. PubMed ID: 33145915
[TBL] [Abstract][Full Text] [Related]
13. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
Qian L; Tcw J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
[TBL] [Abstract][Full Text] [Related]
14. Generation of Human Ventral Midbrain Organoids Derived from Pluripotent Stem Cells.
Sozzi E; Nilsson F; Kajtez J; Parmar M; Fiorenzano A
Curr Protoc; 2022 Sep; 2(9):e555. PubMed ID: 36121202
[TBL] [Abstract][Full Text] [Related]
15. A critical look: Challenges in differentiating human pluripotent stem cells into desired cell types and organoids.
Fowler JL; Ang LT; Loh KM
Wiley Interdiscip Rev Dev Biol; 2020 May; 9(3):e368. PubMed ID: 31746148
[TBL] [Abstract][Full Text] [Related]
16. Neural organoids for disease phenotyping, drug screening and developmental biology studies.
Hartley BJ; Brennand KJ
Neurochem Int; 2017 Jun; 106():85-93. PubMed ID: 27744003
[TBL] [Abstract][Full Text] [Related]
17. Modeling endodermal organ development and diseases using human pluripotent stem cell-derived organoids.
Pan FC; Evans T; Chen S
J Mol Cell Biol; 2020 Aug; 12(8):580-592. PubMed ID: 32652003
[TBL] [Abstract][Full Text] [Related]
18. The myriad possibility of kidney organoids.
Tian P; Lennon R
Curr Opin Nephrol Hypertens; 2019 May; 28(3):211-218. PubMed ID: 30865165
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent Stem Cell-Based Platforms in Cardiac Disease Modeling and Drug Testing.
Shaheen N; Shiti A; Gepstein L
Clin Pharmacol Ther; 2017 Aug; 102(2):203-208. PubMed ID: 28718902
[TBL] [Abstract][Full Text] [Related]
20. The Use of Pluripotent Stem Cell-Derived Organoids to Study Extracellular Matrix Development during Neural Degeneration.
Yan Y; Bejoy J; Marzano M; Li Y
Cells; 2019 Mar; 8(3):. PubMed ID: 30875781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
